SMTL ID : 3srv.2 (1 other biounit)

Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x S19: 2-{[(3R,4R)-3-aminotetrahydro-2H-pyran-4-yl]amino}-4-[(4-methylphenyl)amino]pyrimidine-5-carboxamide(Non-covalent)

S19.1: 16 residues within 4Å: Chain A: L.19, S.21, V.27, A.42, V.75, M.90, E.91, M.92, A.93, G.96, P.97, R.140, N.141, L.143, S.153, D.154 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.19, A:V.27, A:A.42, A:L.143 Hydrogen bonds: A:E.91, A:A.93, A:R.140, A:S.153, A:D.154 Water bridges: A:N.141, A:D.154

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 3 residues within 4Å: Chain A: Q.103, G.211, K.213 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.103 Water bridges: A:K.213

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liddle, J. et al., Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-09-21

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence